Plus therapeutics announces $1.6 million advance payment from cprit

Payment is part of $17.6 million award granted for leptomeningeal cancer targeted radiotherapeutic development program payment is part of $17.6 million award granted for leptomeningeal cancer targeted radiotherapeutic development program
PSTV Ratings Summary
PSTV Quant Ranking